Advertisement

Topics

TruScreen (TRU) - Fast and objective cervical cancer screening

15:12 EST 5 Dec 2018 | Edison Investment Research

Edison Investment Research - Pharmaceutical & healthcare - TruScreen Ltd: TruScreen is focused on the effective commercialisation of its second-generation TruScreen2 optoelectronic cervical cancer screening device, which has already been launched in key target markets. The device provides objective and real-time cervical cancer screening assessments and requires only limited training for the operator, which makes it well-suited for developing countries.
ISIN: NZTRUE0001S7

Original Article: TruScreen (TRU) - Fast and objective cervical cancer screening

NEXT ARTICLE

More From BioPortfolio on "TruScreen (TRU) - Fast and objective cervical cancer screening"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Cervical Cancer
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated using surgery (including local excision) in early stages...